SRZNW icon

Surrozen Inc Warrant
SRZNW

1 day
5 days
1 month
3 months
6 months
Year to date
1 year
5 years
10 years
 

About: Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).

Employees: 44

0
Funds holding %
of 8,072 funds
Positive news %
Price charts implemented using Lightweight Charts™